Introduction
Acute oscillitis is a common upper respiratory infectious disease in primary health-care institutions, mainly caused by viruses or bacterial infections, of which group A B is the more common scab. If the treatment is not timely or appropriate, complications such as Chinese ear, sinus and acute renal inflammation may arise, with significant health effects. Romanic erythroacin, a commonly used macrocyclic ester antibiotics, is important in the treatment of acute oscillitis at the grass-roots level. Scientificly rational use of erythroacin is essential to improve efficacy, reduce adverse effects and avoid the abuse of antibiotics.
II. OVERVIEW OF ACHIEVEMENTS
3. Incidence mechanisms
– Virus infections are common causes of acute oscillitis, such as nasal viruses, coronal viruses, etc., and the virus is adhesive in the respiratory tract. Following the membrane, there is a local mass of reproduction, resulting in mucous membranes filled with blood, oedema and inflammation of inflammating cells. When the resistance of the organism is reduced, bacteria can regenerate, and group A type B soluble streptocycoccus can produce a variety of toxins and enzymes, further damage mucous tissue, increase in inflammation reactions, and cause osteal pain, heat, etc.
Epidemiological characteristics
– Acute oscillitis can occur in all age groups, but in children and young people. The incidence is higher when season shifts and temperature changes are high, such as in autumn and winter. In addition, mass centres, such as schools, kindergartens, etc., are prone to local epidemic transmission, mainly through foaming or close contact.
III. Pharmacological properties of roacin
3. Antibacterial spectra
– Rothacin has a high level of antibacterial activity for gland positive bacteria, such as yellow streptococcus and streptococcus, as well as for some gland vaginal bacteria, such as haemophilus influenzae and cartamola. In particular, there are better inhibitions and extinctions for common strains that cause acute oscillitis, such as type B streptococcus. It acts as a microbacterial resistance by inhibiting the synthesis of bacterial proteins in combination with bacterial nuclei 50S Aki.
4. Pharmaceutical dynamics
– Good absorption and high bioavailability of roacin after oral exposure. It is widely distributed in the body and can enter organizations such as tonsils and larvae, where high levels of drugs can be achieved, which can contribute to the antibacterial response to local infections. It has a relatively long plasma half-life, typically 8 – 15 hours, which makes the daily use of medicines relatively small, usually 1-2 times a day, easy to use and increases drug dependence.
IV. APPLICATION OF RODRICICIN TO THE TREATMENT OF ACHIEVEMENTS IN GROUND MEDICAL AGENCIES
6. Application
– When acute osteoporosis is affected by fever, severe osteoporosis, and the mucous membranes are clearly plethorad with septums, regular blood tests indicate an increase in the total number of white cells and the proportion of neutral particles, and when the potential for bacterial infection is considered high, especially if it is suspected of being a group A B streptocytosis. For those who are allergic to penicillin-type drugs, erythrin is also a suitable alternative. However, if acute oscillitis is caused by simple viral infections and, in the absence of evidence of a combination of bacterial infections, antibiotics such as roacin are not generally recommended for treatment, there should be support for treatment, such as drinking water, rest, use of venom, etc., because of the ineffectiveness of antibiotic infections and increased risk of bacterial resistance.
7. Usage
– The common dose of erythroacin is 150 mg per day for adults and 2 times per day for children based on body weight, generally 2.5 – 5 mg/kg per day. It can be administered at an empty stomach of 3 – 4 hours before or after meals to increase the absorption of drugs. Medical staff at the primary level should provide accurate information on the methods used by patients or their families to ensure the correct use of drugs.
8. Course determination
– Generally, erythroacin treatment for acute oscillitis is 5-10 days. For patients with milder symptoms and low levels of infection, there may be a marked improvement in symptoms in about five days, but at least five days of treatment are still required to completely remove the pathogens and prevent recurrence. The procedure may be extended, as appropriate, to 10 days for patients with a more serious condition, with a high degree of infection or with a tendency to cause complications. In the course of the treatment, the physician at the primary level shall determine, on the basis of the patient ‘ s symptoms, signs and the necessary laboratory examinations (e.g., a review of the blood protocol), whether the procedure needs to be adjusted.
9. Joint medical attention
– In basic medical practice, joint use of medicines is sometimes considered. For example, for patients with high heat and severe pain, a combination of antithermal analgesics, such as Broven, can be used to mitigate symptoms quickly. However, attention needs to be paid to the interaction between drugs, where erythroacin, when used in combination with certain drugs, such as tea alkalis, may increase the blood concentration of tea alkalis and lead to tea alkalis poisoning, so co-use should closely monitor the concentration of tea alkalis and adjust the dose. When co-existed with geo-sincin, it is likely to increase the absorption of geo-sincin, as well as the need to monitor carefully and monitor the concentration of geo-sincinine. Co-use of antiacids such as aluminium, magnesium and so forth may affect the absorption of roacin, which should be avoided at the same time and taken after 1 – 2 hours.
10. Monitoring adverse effects
– The most common adverse effects of roacin are gastrointestinal reactions, such as nausea, vomiting, abdominal pain, diarrhoea, etc., which are generally mild and most patients are resistant. During the course of the patient ‘ s medication, medical staff at the primary level should ask if the patient is suffering from gastrointestinal disorders, and if the symptoms are light, the patient may be informed of appropriate feeding before taking the medication or adding a gastric mucous protection agent such as sulfur aluminum. A small number of patients may have allergies such as rashes, itchings, etc., and should be stopped as soon as they occur and treated in accordance with the severity of allergies, such as the use of antimontamines. In addition, erythroacin may cause hepatic abnormalities, such as aminocyte, which should be monitored regularly for patients with underlying liver function diseases or with long therapeutic procedures, both before and during use, such as a review of liver function indicators every 1-2 weeks, in order to detect and address liver function damage in a timely manner.
Conclusions
When using erythroacin for the treatment of acute oscillitis, primary medical institutions need to have a comprehensive understanding of the mechanisms and epidemiological characteristics of acute oscillitis, are familiar with the pharmacological properties of roacin and have a strict understanding of its application, usage, treatment process determination, joint medical care and adverse response monitoring. Only the scientifically sound application of erythroacin can improve the treatment of acute oscillitis, reduce the incidence of adverse reactions, avoid the abuse of antibiotics and guarantee the safety and health of patients at the grass-roots level. At the same time, medical personnel at the primary level should strengthen health education for the patients, inform them of the importance of rational use of medicines and of care during their use, promote their active cooperation in treatment and increase the rate of cure of diseases.
